跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL Aciclovir 500mg/20mL Intravenous infusion injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DBL Aciclovir 500mg/20mL Intravenous infusion injection vial
Approved
STANDARD
DBL Aciclovir 500mg/20mL Intravenous infusion injection vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
dffae5b2d257ec47
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
dffae5b2d257ec47
Product Name
DBL Aciclovir 500mg/20mL Intravenous infusion injection vial
Artg Id
56810
Artg Name
DBL Aciclovir 500mg/20mL Intravenous infusion injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1996-08-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1c538ed12d31b7413dcdc758aa00fccc.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/24b49d0884a286bdd76a18f7305e909d.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
dffae5b2d257ec47
Type
Standard
Back to TGA Approvals